Equities

CS Diagnostics Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
CSDX:QBB

CS Diagnostics Corp

Actions
  • Price (USD)0.2238
  • Today's Change-0.014 / -5.99%
  • Shares traded8.10k
  • 1 Year change-72.03%
  • Beta5.2915
Data delayed at least 15 minutes, as of Feb 10 2026 20:47 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

CS Diagnostics Corp is a Germany-based medical technology and distribution company. The Company is focused on developing and commercializing therapeutic and preventive solutions to improve patient care and outcomes. Its primary products are CS Protect-Hydrogel, a tissue spacer gel designed for use in radiation therapy, and MEDUSA, a surface disinfectant. CS Protect Hydrogel is an injectable organ spacer initially targeted for prostate cancer radiotherapy, where it increases the distance between the prostate tumor and the rectum to reduce radiation damage to healthy tissue. It is ready-to-use (pre-mixed in a sterile package) rather than requiring on-site mixing by clinicians. MEDUSA’s formulation provides an extended duration of antimicrobial protection on surfaces. It includes color-changing test strips that allow users to verify the concentration of the active ingredient over time.

  • Revenue in USD (TTM)0.00
  • Net income in USD-341.62k
  • Incorporated2010
  • Employees5.00
  • Location
    CS Diagnostics CorpStresemannallee 4bNEUSS 41460GermanyDEU
  • Phone+49 21 311510871
  • Websitehttps://csdcorp.us/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
electroCore, Inc.29.84m-14.16m42.78m73.00------1.43-1.70-1.703.59-0.14051.412.6329.39408,698.60-66.70-65.38-126.40-87.8786.0480.72-47.46-159.341.33--1.20--57.0960.1536.89------
EUDA Health Holdings Ltd5.16m-2.06m45.37m117.0077.67----8.790.01550.08760.1483-0.09982.49--17.1044,104.96-100.77------22.39---40.53--0.2084-46.54----8.22---108.62------
Neuraxis Inc3.36m-8.37m46.45m21.00--18.90--13.81-1.02-1.020.40590.23110.97187.9441.74160,111.00-217.93---1,360.57--84.34---224.24--1.55-97.220.0789--9.18--42.21------
Spectral AI Inc23.17m-16.37m47.57m78.00------2.05-0.7206-0.72060.9706-0.3011.7228.4112.12297,025.70-121.66------45.01---70.64--0.8252-11.99----63.83--26.56------
Heartbeam Inc0.00-20.62m49.25m16.00--120.95-----0.6638-0.66380.000.01180.00----0.00-432.60-142.55-792.01-190.45------------0.00-------32.85------
Sharps Technology Inc2.51m-104.37m50.74m5.00--0.1116--20.20-690.20-690.200.395715.680.0111.81--502,354.00-45.86-86.10-47.44-125.430.1489---4,155.30--3.67--0.0173------5.54--65.50--
Nutriband Inc2.28m-34.59m51.87m13.00--6.86--22.76-3.07-3.070.20030.6210.21749.9617.72---121.91-66.47-134.92-78.0433.5037.16-560.85-340.947.35--0.022--2.6041.99-91.10------
Alpha Pro Tech Ltd59.10m3.68m55.53m130.0015.700.881412.330.93970.34150.34155.466.080.8031.6410.62454,584.605.0013.855.2314.5838.2140.646.2312.787.70--0.000.00-5.544.39-6.215.5424.04--
Medinotec Inc11.43m2.34m58.78m51.0025.0810.6924.695.140.19940.19940.97340.46791.874.047.03224,166.5038.33--49.87--58.25--20.48--3.8937.940.00008--81.53--633.61------
CS Diagnostics Corp0.00-341.62k59.50m5.00---------531,454.00-531,454.00----0.00-------579.61-1,264.84-----------209,220.50------------32.83------
Pulmonx Corp91.66m-56.75m63.52m291.00--1.06--0.693-1.41-1.412.281.460.59971.477.20314,996.60-37.13-26.27-42.91-28.9673.3072.91-61.91-89.484.15--0.3821--22.0120.787.31--14.98--
QT Imaging Holdings Inc11.50m-19.51m63.81m20.00------5.55-2.09-2.091.27-0.9391.201.346.57574,821.50-204.52---4,313.85--50.81---169.73--0.4745-2.0280.26--11,987.88---132.34------
Forian Inc28.11m-852.58k64.94m1.00--2.08--2.31-0.0274-0.02740.90241.000.5692--4.4628,106,910.00-1.73-24.90-2.92-29.2355.4071.84-3.03-67.83----0.00---5.015.68-257.42------
Accuray Inc436.97m-35.62m65.51m990.00--1.23--0.1499-0.2982-0.29823.890.47130.94342.105.90441,382.80-7.69-1.60-13.56-2.7227.8335.04-8.15-1.750.7091-0.38320.7178--2.683.6789.77--2.76--
DarioHealth Corp24.73m-37.11m69.68m196.00--0.9312--2.82-12.47-12.478.2911.070.21732.226.51126,183.70-37.17-63.89-42.41-75.3056.8634.31-171.09-262.344.02-69.690.2901--32.8629.0435.47--7.09--
InspireMD Inc7.78m-46.20m75.00m85.00--1.16--9.64-0.8396-0.83960.1391.530.12071.934.4691,517.65-71.65-60.63-83.34-71.7724.9120.76-593.89-377.986.17--0.00--12.9613.50-60.70--37.62--
Data as of Feb 10 2026. Currency figures normalised to CS Diagnostics Corp's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.